PRESS RELEASE published on 09/11/2023 at 19:53, 1 year 2 months ago Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
PRESS RELEASE published on 09/11/2023 at 13:00, 1 year 2 months ago Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
PRESS RELEASE published on 09/08/2023 at 22:37, 1 year 2 months ago Moderna Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
PRESS RELEASE published on 09/06/2023 at 22:30, 1 year 2 months ago Moderna to Participate at Morgan Stanley 21st Annual Global Healthcare Conference
PRESS RELEASE published on 09/06/2023 at 13:00, 1 year 2 months ago Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine Generates Strong Immune Response in Humans Against BA.2.86
PRESS RELEASE published on 08/30/2023 at 13:00, 1 year 2 months ago Moderna to Host Investor Event - R&D Day and Business Updates
PRESS RELEASE published on 08/17/2023 at 22:15, 1 year 3 months ago Moderna Clinical Trial Data Confirm Its Updated COVID-19 Vaccine Generates Robust Immune Response in Humans Against Widely Circulating Variants
PRESS RELEASE published on 08/03/2023 at 12:30, 1 year 3 months ago Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates
PRESS RELEASE published on 07/13/2023 at 13:00, 1 year 4 months ago Moderna to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
PRESS RELEASE published on 07/05/2023 at 13:00, 1 year 4 months ago Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345
Published on 11/22/2024 at 00:00, 2 hours 22 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 4 hours 17 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 4 hours 32 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 6 hours 7 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 6 hours 12 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 19:01, 7 hours 20 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 7 hours 45 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 8 hours 23 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 8 hours 30 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 8 hours 30 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 19 hours 24 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 7 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 8 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 8 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 18 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
